Medical Net, Inc. (3645) has 7 disclosed large-shareholding filings and 3 disclosed disposals on record, filed by 3 distinct investors. Together those filings cover ¥317M ($2.0M) in reported transaction value. The earliest filing StockDrifts holds for Medical Net, Inc. is dated 2021-07-01; the most recent is 2025-10-31. Across these filings the average return since disclosure is -18.61%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Purpose | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2025-10-31 | BUY | Market Buy | 平川 大 Hirakawa Dai | activist | 886.5K | ¥306 | -15.4% | ¥32M ($208K) |
| 2025-10-31 | BUY | negotiated | 平川 大 Hirakawa Dai | activist | 886.5K | ¥306 | - | ¥32M ($208K) |
| 2024-12-19 | SELL | unknown | 株式会社SBI証券 SBI SECURITIES Co.,Ltd. | other | 451.6K | ¥311 | +16.7% | ¥64M ($415K) |
| 2024-10-21 | BUY | unknown | 株式会社SBI証券 SBI SECURITIES Co.,Ltd. | other | 658.2K | ¥327 | -20.8% | ¥215M ($1.4M) |
| 2024-05-21 | SELL | unknown | 株式会社SBI証券 SBI SECURITIES Co.,Ltd. | other | 477.3K | ¥379 | +31.7% | ¥71M ($461K) |
| 2023-11-21 | BUY | Market Buy | 株式会社SBI証券 SBI SECURITIES Co.,Ltd. | other | 665.8K | ¥364 | -28.9% | ¥45M ($293K) |
| 2023-10-19 | BUY | unknown | 株式会社SBI証券 SBI SECURITIES Co.,Ltd. | other | 540.6K | ¥335 | -22.7% | ¥181M ($1.2M) |
| 2023-10-05 | SELL | unknown | 株式会社SBI証券 SBI SECURITIES Co.,Ltd. | other | 454.1K | ¥360 | +28.1% | ¥49M ($318K) |
| 2023-07-21 | BUY | unknown | 株式会社SBI証券 SBI SECURITIES Co.,Ltd. | other | 591.2K | ¥363 | -28.6% | ¥215M ($1.4M) |
| 2022-10-05 | BUY | Market Buy | 平川 裕司 Hirakawa Yuji | activist | 783.5K | ¥429 | -39.6% | ¥70M ($450K) |
| 2021-09-30 | BUY | Market Buy | 平川 大 Hirakawa Dai | activist | 780.7K | ¥581 | -55.4% | ¥93M ($602K) |
| 2021-07-01 | BUY | negotiated | 平川 裕司 Hirakawa Yuji | activist | 310.3K | ¥660 | - | - |
| 2021-07-01 | BUY | negotiated | 平川 裕司 Hirakawa Yuji | activist | 310.3K | ¥660 | - | ¥205M ($1.3M) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Japan insider signal tier research, or browse every Japanese stock we track.